Macrophage Polarization States in the Tumor Microenvironment
Open accessThe DOI matches its Crossref record; 147 of the 148 references it cites were found in a registry or an index.
Abstract
The M1/M2 macrophage paradigm plays a key role in tumor progression. M1 macrophages are historically regarded as anti-tumor, while M2-polarized macrophages, commonly deemed tumor-associated macrophages (TAMs), are contributors to many pro-tumorigenic outcomes in cancer through angiogenic and lymphangiogenic regulation, immune suppression, hypoxia induction, tumor cell proliferation, and metastasis. The tumor microenvironment (TME) can influence macrophage recruitment and polarization, giving way to these pro-tumorigenic outcomes. Investigating TME-induced macrophage polarization is critical for further understanding of TAM-related pro-tumor outcomes and potential development of new therapeutic approaches. This review explores the current understanding of TME-induced macrophage polarization and the role of M2-polarized macrophages in promoting tumor progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies have shown that MSCs have the ability to polarize M1 pro-inflammatory macrophages towards an alternative M2 anti-inflammatory phenotype [21,22,23].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [21]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In addition, CD4+ T cells impact cancer immunology (30), M1 macrophages suppress tumors, and M2 macrophages aid tumor growth (31).”
From A multimodal and fully automated system for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer (2025) · cites this paper as [31]
The cited source says what the claim attributes to it.
In the citing paper
“In addition, CD4+ T cells impact cancer immunology (30), M1 macrophages suppress tumors, and M2 macrophages aid tumor growth (31).”
From A multimodal and fully automated system for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer (2025) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 3×
“These CD8+ T and NK cells express high levels of cytokines such as IFN-γ, GM-CSF, and TNF-α as well as chemokines such as CCL4, CCL5, and CCL23 that assist in the further recruitment of immune cells and the signaling of anti-tumorigenic pathways [73,74].”
BackgroundMyeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753 · cited 2×
“MDSCs express high levels of both iNOS and arginase-1, which both play a direct role in suppression of T-cell function [95].”
BackgroundOrigin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618 · cited 1×
“Inflammation can be triggered by conditions such as infection or injury or can be systemic as seen in type 2 diabetes and cardiovascular disease [59].”
BackgroundMacrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335 · cited 3×
“Current literature supports the theory that most TAMs originate from either tissueresident embryonic macrophages or macrophages derived from circulating monocytes that originate in the bone marrow [87].”
BackgroundMANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 3×
“The significance of macrophage heterogeneity has been under review since the early 2000s and has been linked to many malignancies and autoimmune disorders in recent years [66].”
BackgroundProtective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269 · cited 1×
“The resolution of inflammation is led by the deactivation of these inflammatory mediators, permitting either the apoptosis of pro-inflammatory M1 macrophages or the transition to an anti-inflammatory M2 macrophage [64].”
BackgroundMacrophage biology in development, homeostasis and disease
Wynn, T. A., Chawla, A., & Pollard, J. W. (2013) · Nature · doi:10.1038/nature12034 · Cited by 4,684 · cited 15×
“Macrophages are found in every human tissue in the body and exhibit anatomical and functional diversity [4].”
BackgroundInfluentialMurray, P. J. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034339 · Cited by 2,981 · cited 2×
“Some noncytokine, extrinsic pathways of macrophage polarization do exist, however, including hypoxia as well as the production of lactate within tumors, which drive M2 polarization [36].”
BackgroundFibroblast growth factor signalling: from development to cancer
Turner, N., & Grose, R. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2780 · Cited by 2,693
Cited by
Items 601–700 of 1,000
Research on the biological mechanism and potential application of CEMIP
Liu, Y., Hu, G., Li, Y., Kong, X., Yang, K., Li, Z., Lao, W., Li, J., Zhong, J., Zhang, S., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1222425 · Cited by 14
Yang, M., Cai, W., Lin, Z., Tuohuti, A., & Chen, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914808 · Cited by 13
“Most of the macrophages in tumor tissues have the phenotype and function of M2 macrophages; therefore, specific M2 morphological macrophages that exert immunosuppressive and protumor effects are narrowly defined as TAMs [14,15].”
BackgroundSystems Biology and Cytokines Potential Role in Lung Cancer Immunotherapy Targeting Autophagic Axis
Khilwani, R., & Singh, S. (2023) · Biomedicines · doi:10.3390/biomedicines11102706 · Cited by 12
“In contrast, the effector function of M2 macrophages is brought upon by anti-inflammatory mediators like IL-4, IL-13 [112], and MCSF [113] generated by immune cells.”
BackgroundTargeting the αVβ3/NgR2 pathway in neuroendocrine prostate cancer
Testa, A., Quaglia, F., Naranjo, N. M., Verrillo, C. E., Shields, C. D., Lin, S., Pickles, M. W., Hamza, D. F., Schalscha, T. V., Cheresh, D. A., et al. (2023) · Matrix Biology · doi:10.1016/j.matbio.2023.11.003 · Cited by 12
“…an imbalance between M1 and M2 in favor of M2 in the TME, appears to be associated with tumor growth, angiogenesis, and metastasis [42,47,48]. sEVs have been recognized not only as important mediators of communication among the various components of the TME [41], but also, when isolated…”
BackgroundMall, R., & Kanneganti, T. (2023) · Scientific Reports · doi:10.1038/s41598-023-48098-1 · Cited by 13
“Similarly, increased M1 macrophage (∆μ(CF) = 0.093), historically regarded as anti-tumorigenic 61 , as well as increased infiltrating cytotoxic CD8 + T cell (∆μ(CF) = 0.091) and B cell (∆μ(CF) = 0.026) fractions, and decreased monocyte (∆μ(CF) = − 0.077) fractions, which are often…”
BackgroundInfluentialRole of the ubiquitin–proteasome system on macrophages in the tumor microenvironment
Xiao, Y., Liu, R., Li, N., Li, Y., & Huang, X. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31180 · Cited by 12
Rezagholizadeh, F., Tajik, F., Talebi, M., Taha, S. R., Zadeh, M. S., Farhangnia, P., Hosseini, H. S., Nazari, A., Ghomi, S. M., Mousavi, S. M. K., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1283364 · Cited by 14
“CD68 is a commonly used marker to detect M2-like TAMs in the TME, which have been shown to promote cancer growth and metastasis through various mechanisms, including immune suppression and angiogenesis (38, 39).”
BackgroundSun, J.-R., Kong, C., Ye, Y., Wang, Q., Qu, X.-K., Jia, L., & Wu, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-57714-7 · Cited by 12
“ESTIMATE analysis further suggested that the HRG group had a higher stromal score, immune score, and estimated score when compared with the LRG(Fig.”
BackgroundInfluentialTargeting tumor-associated macrophages to reverse antitumor drug resistance
Li, S., Sheng, J., Zhang, D., & Qin, H. (2024) · Aging · doi:10.18632/aging.205858 · Cited by 16
Tsai, P., Chen, S., Liu, R. H., Chen, C., Chen, W., Ng, Y., & Kuan, Y. (2021) · Toxics · doi:10.3390/toxics9110276 · Cited by 12
Combined Cancer Immunotheranostic Nanomedicines: Delivery Technologies and Therapeutic Outcomes
Nasser, T., Adel, R., Badr, A., Teleb, M., Bekhit, A. A., Elkhodairy, K. A., Abdelhamid, A. S., & Elzoghby, A. O. (2023) · ACS Omega · doi:10.1021/acsomega.2c05986 · Cited by 12
Acetylation increases expression, interaction with TRAPPC4 and surface localization of PD-L1
Romeo, M. A., Montani, M. S. G., Santarelli, R., Benedetti, R., Arena, A., & Cirone, M. (2023) · Discover Oncology · doi:10.1007/s12672-023-00766-4 · Cited by 11
Nie, C., Ma, T., Ye, J., He, M., Zhang, T., Wei, K., Jiang, J., & Chu, X. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.149901 · Cited by 11
Lin, Y., Lin, L., Huang, H., Wen, X., Zhang, Y., Zhang, R., & Huang, W. (2024) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000519 · Cited by 11
“Among them, macrophages as one of the important components in the tumor immune microenvironment (TIME), 14 we would like to further investigate the effect of tumor-associated macrophages (TAM) on human-derived triple-negative breast cancer after vitexin induction.”
Freeman, P., Bellomo, G., Ireland, L., Abudula, M., Luckett, T., Oberst, M. D., Stafferton, R., Ghaneh, P., Halloran, C. M., Schmid, M. C., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1382538 · Cited by 13
Li, L., Wang, X., Jiang, M., Li, L., Wang, D., & Li, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117420 · Cited by 11
Kim, J. Y., Kang, W., Yang, S., Park, S. H., Ha, S. Y., & Paik, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-72721-4 · Cited by 12
Chen, X., Zhao, Z., Zhao, R., Li, W., Liu, X., Tian, L., & Liu, M. (2025) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-024-03915-y · Cited by 11
“…M1 macrophages display tumor-suppressing capabilities, while M2-polarized macrophages, often referred to as tumor-associated macrophages (TAMs), have been documented to regulate critical processes linked to malignancy, including promotion of immune suppression, and tumor cell proliferation [11–13].”
Liu, G., Huang, K., Lin, B., Zhang, R., Zhu, Y., Dong, X., Wu, C., Zhu, H., Lin, J., Bao, M., et al. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167690 · Cited by 11
Huang, Q.-T., Ma, X., Zhang, J., Lin, W., Shen, X.-X., Huang, Z.-W., Zhang, X., Wu, X.-Y., Dou, Y., Su, Z., et al. (2025) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x25500119 · Cited by 11
Mohammad, S. I., Theab, E. Y., Vasudevan, A., Bishoyi, A. K., Ballal, S., Al‐Hetty, H. R. A. K., Shankhyan, A., Anupria, A., Panigrahi, R., & Yasin, H. A. (2025) · Seminars in Oncology · doi:10.1016/j.seminoncol.2025.152365 · Cited by 11
Taurine and cancer: Biological properties and multifaceted roles in cancer progression
Liu, R., Li, X., Hua, Z., Liu, Z., Wang, Z. F., & Li, X. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189403 · Cited by 11
Stimuli-Responsive Drug Delivery Systems for Enhanced Melanoma Immunotherapy
Zhang, G., Zhang, X., Dong, Q., Kong, S., Chen, L., Zhang, X., Gao, J.-Q., Zhang, J., & Ding, B. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s517331 · Cited by 12
“92 Moreover, the antigen presentation ability of immune cells determines the effectiveness of the immune response, and the absence of antigen presentation in melanoma tumors reduces the T-cell activation, which induces immunosuppression.”
Fu, J., Wei, C., Chen, Y., Xiao-ming, H., & Zhang, K. (2025) · Hereditas · doi:10.1186/s41065-025-00534-0 · Cited by 11
“It is reported that under the influence of the complex tumor micro-environment (TME), macrophages are recruited to the tumor area and polarized into either the M1 state, which suppresses tumor growth, or the M2 state, which enhances tumor growth [24–26].”
Enhancing natural killer cell anti-tumour activity through macrophage manipulation
Palmer, N., Khakoo, S. I., Sánchez-Elsner, T., & Vallejo, A. F. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1656925 · Cited by 12
“In early-stage tumours, macrophages may exhibit immunostimulatory phenotypes and exert tumoricidal functions (64), partly through nitric oxide production (65), and have been associated with improved clinical outcomes in colorectal (66), lung (67), ovarian (68), and breast cancers (69).”
The Dual Role of PDCD10 in Cancers: A Promising Therapeutic Target
Liu, J., Zhao, K., Wu, S., Li, C., You, C., Wang, J., Shu, K., & Lei, T. (2022) · Cancers · doi:10.3390/cancers14235986 · Cited by 14
Azulay, M., Shahar, M., Shany, E., Elbaz, E., Lifshits, S., Törngren, M., Friedmann, A., Kramer, R. E., & Hedlund, G. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04064-z · Cited by 12
Sui, B., Zhao, J., Ding, T., Ruan, M., Sun, J., & Liu, X. (2023) · Applied Materials Today · doi:10.1016/j.apmt.2023.101813 · Cited by 13
Wang, X., Wei, S., Li, W., Wei, X., Zhang, C., Dai, S., Ma, M., Zhao, L., & Shan, B. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110213 · Cited by 12
Yokota, S., Kaji, K., Yonezawa, T., Momoi, Y., & Maeda, S. (2023) · The Veterinary Journal · doi:10.1016/j.tvjl.2023.105992 · Cited by 11
Li, J., Yu, L., Zhao, X., & Wu, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1196054 · Cited by 12
“ROS induce more antigenic stimuli at appropriate levels to stimulate antitumor immunity (36, 37), and more antitumor immune signals undoubtedly enhance tumor killing by effector immune cells (38, 39).”
BackgroundLi, D., Du, F., Jiao, H., Zhang, F., Wang, X., & Zhang, S. (2023) · Biochemical Genetics · doi:10.1007/s10528-023-10482-x · Cited by 11
“In addition to the uncontrolled cell growth and division, immunoregulation mediated by immune system cells, such as macrophages, has significant effects on cancer development and metastasis (Ren et al. 2022; Boutilier and Elsawa 2021).”
Gao, X., Long, R., Qin, M., Zhu, W., Wei, L., Dong, P., Chen, J., Luo, J., & Feng, J. (2023) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2023.5327 · Cited by 12
“…(LPS) and interferon‑ γ (IFN‑ γ ), is associated with the antitumor response. conversely, the generation of M2‑type macro‑ phages, mainly induced by interleukin (IL)‑4 and IL‑13, promotes tumor immune escape, highlighting a crucial role of this type of TAMs in cancer progression (14,15).”
BackgroundQin, X., Ha, S., Chen, L., Zhang, T., & Li, M. (2023) · Nutrients · doi:10.3390/nu15234882 · Cited by 14
RNAkines are secreted messengers shaping health and disease
Li, J., Fang, J., Jiang, X., Zhang, Y., Vidal‐Puig, A., & Zhang, C. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.12.004 · Cited by 16
“Hypoxia also has a role in M2 polarisation through cancer cell-secreted RNAkines, including miR-21-3p [94], miR-125b-5p [94], miR-181d-5p [94], miR-301a-3p [95], and circ0048117 [96].”
Li, W., Ye, Q., Jiang, Z., Xia, D., Yan, Z., Wang, D., Chen, Y., Cao, T., Wang, J., Lin, C., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.132089 · Cited by 11
Liu, Q., Sun, Y., Zhang, T., Lin, W., Zhang, J., Zhang, H., Zheng, W., Xu, H., & Zhou, F. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1512086 · Cited by 11
“Among the key players in the TME are tumor-associated macrophages (TAMs), which are highly plastic immune cells within the tumor microenvironment, capable of adopting distinct M1 or M2 phenotypes in response to local signals (9, 10).”
Mavuluri, J., Dhungana, Y., Jones, L. L., Bhatara, S., Shi, H., Yang, X., Lim, S.-E., Reyes, N., Chi, H., Yu, J., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0841 · Cited by 13
“Multiple cues prompt the recruitment and differentiation of macrophages in the TME (42).”
Unveiling the Role of the Tumor Microenvironment in the Treatment of Follicular Lymphoma
Clemente, M. B., Collazo-Lorduy, A., Yanguas‐Casás, N., Calvo, V., & Provencio, M. (2022) · Cancers · doi:10.3390/cancers14092158 · Cited by 11
“At early stages of tumor development, M1-macrophages are predominant, while the M2-phenotype is more frequent in the advanced setting where tumor proliferation and invasion increases [32].”
BackgroundLu, Y., Feng, N., Du, Y., & Yu, R. (2022) · Nanomaterials · doi:10.3390/nano12162832 · Cited by 12
“tion in the amounts of TAMs as well as in transit pro-tumor M2-TAM into anti-tumor M1-TAM [137].”
BackgroundInfluentialWaldenström Macroglobulinemia: Mechanisms of Disease Progression and Current Therapies
Boutilier, A. J., Huang, L., & Elsawa, S. F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911145 · Cited by 11
“The bone marrow is made up of a collection of immune and non-immune cells, including T-cells, B-cells, macrophages, myeloid-derived suppressor cells, mast cells, mesenchymal stem cells, osteoclasts, osteoblasts, natural killer cells, and dendritic cells [15] (Figure 1).”
BackgroundInfluentialSelf-citationGhalavand, M., Moradi‐Chaleshtori, M., Dorostkar, R., Mohammadi‐Yeganeh, S., & Hashemi, S. M. (2023) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2473 · Cited by 13
Roles of circRNA dysregulation in esophageal squamous cell carcinoma tumor microenvironment
Li, J., Song, Y., Cai, H., Zhou, B., & Ma, J. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1153207 · Cited by 10
Huang, Z., Xie, T., Xie, W., Chen, Z., Wen, Z., & Yang, L. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1428018 · Cited by 12
“They induce immunosuppression, participate in pro-carcinogenic functions, and promote tumor growth and metastasis (58 – 60).”
BackgroundChen, W., Xu, H., Guo, L., Zheng, F., Yao, J., & Wang, L. (2024) · MedComm · doi:10.1002/mco2.706 · Cited by 13
“14,16,17 20 Research has shown that in pathological liver conditions, there are abnormal changes in the total BA levels in the body.”
BackgroundCAR T-cells for pediatric solid tumors: where to go from here?
Trautmann, T., Yakobian, N., & Nguyen, R. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10214-6 · Cited by 12
Goswami, R., Nabawy, A. M., Jiang, M., Çiçek, Y. A., Hassan, M. A., Nagaraj, H., Zhang, X., & Rotello, V. M. (2024) · Nanomaterials · doi:10.3390/nano14191556 · Cited by 11
“M1-like macrophages, usually activated by interferon-gamma (IFN-γ ) and lipopolysaccharide (LPS), are typically involved in pro-inflammatory responses, producing reactive oxygen and nitrogen species and phagocytosing antigens to combat pathogens and tumors [8,9].”
BackgroundThe novel immune landscape of immune‐checkpoint blockade in EBV ‐associated malignancies
Zhang, F., Li, W., Zheng, X., Ren, Y., Li, L., & Yin, H. (2024) · The FASEB Journal · doi:10.1096/fj.202301980rr · Cited by 11
“61 Recent research has indicated that EBV infection could accelerate the transition of TAMs to M2 polarization by activating the ATR pathway in NPC, which fosters the growth of subcutaneous xenografts.”
Ion channels in macrophages: Implications for disease progression
Li, X., Du, Y.-X., Yu, C., & Niu, N. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113628 · Cited by 12
Zhang, Y., Jia, Z., Cao, D., Zhong, Y., Wu, Y., Fu, Y., Cui, Y., Yu, X., Liu, Y., & Jiang, J. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167711 · Cited by 12
Qi, Y., Li, Q., Chen, L., Zhao, S., Nie, J., & Liu, G. (2025) · CytoJournal · doi:10.25259/cytojournal_241_2024 · Cited by 12
“[13] The interplay between ferroptosis and macrophage polarization remains poorly understood, especially in EOC, where the immune microenvironment plays a critical role in tumor progression.”
Lee, E., Dang, L. N., Choi, J., Kim, H., Bastatas, L. D., & Park, S. (2025) · Advanced Science · doi:10.1002/advs.202502073 · Cited by 12
Xue, Y., Chen, J., Sun, X., Su, C., Fan, S., Song, X., Deng, R., & Hao, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-03113-5 · Cited by 10
Promotion of rat femoral distal bone defect repair using alginate-silk fibroin composite hydrogel
Gong, D., Zhai, Q., Wu, M., Tao, X., & Wang, F. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114973 · Cited by 10
Rajneesh, Tiwari, R., Singh, V. K., Kumar, A., Mehrotra, S., Gautam, V., Neville, J. F., Bansal, V., Pathak, R., Singh, A. K., et al. (2025) · Biology · doi:10.3390/biology14091109 · Cited by 10
Liu, Q., Luo, J., Wang, H., & Cui, S. (2025) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70159 · Cited by 12
“While previous studies have emphasized the critical role of macrophage phenotypic modulation in inflammation and tissue repair, achieving precise control over macrophage behaviour remains a major therapeutic challenge (Boutilier and Elsawa 2021; Wang et al. 2021; Cheng et al. 2021).”
Ran, B., Xiao, L., Liu, Y., Zhang, C., Kong, L., Zhang, Y., Gu, X., Jiang, C., & Wu, J. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.09.025 · Cited by 16
“Arg1 and inducible nitric oxide synthase (iNOS) determine the utilization of arginine pathways and the polar direction in TAMs [97].”
Hejazi, M., Heshmat, R., Shafiee, G., Larijani, B., Mokhtarzadeh, A. A., Ebrahimi, V., & Tavangar, S. M. (2025) · Cancers · doi:10.3390/cancers17203373 · Cited by 10
“Some lncRNAs, such as LINC00657, and SLC26A4-AS1, are associated with polarized immune cell types that may also affect the tumor microenvironment and may suggest drug and/or immunotherapy responses [111,112].”
Xu, A.-L., Xu, S., Tan, X., Sun, Q., Song, Y., Nong, Y., Wang, X., Zeng, Y., Fan, H., & Zhou, Y. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s543139 · Cited by 11
“7 Also, macrophages exhibit remarkable plasticity, enabling them to adapt to different microenvironmental stimuli and differentiate into various functional phenotypes, a process known as macrophage polarization.”
Trejo, J., Koegeboehn, H., Faizuddin, F., Logan, R., Toutoungy, M., Sheikh, A. A., Fandy, T. E., Saucedo, S., Vasquez, V., Nguyen, T., et al. (2026) · Cells · doi:10.3390/cells15020136 · Cited by 11
“The M2 polarization state of tumor-associated macrophages (TAMs) is not fixed and can be modulated under certain conditions [109,110].”
Ålgars, A., Kemppinen, L., Fair-Mäkelä, R., Mustonen, H. K., Haglund, C. H., & Jalkanen, S. (2021) · Cancers · doi:10.3390/cancers13235988 · Cited by 12
“TAMs promote angiogenesis and lymphangiogenesis in tumor tissue by several mechanisms, such as the secretion of pro-angiogenic factors including vascular endothelial growth factors [15,61].”
BackgroundMethodZhang, C., Peng, L., Gu, H., Wang, J., Wang, Y., & Xu, Z. (2023) · Scientific Reports · doi:10.1038/s41598-023-28527-x · Cited by 11
Gayer, F. A., Henkel, M., Luft, J., Reichardt, S. D., Fichtner, A., Legler, T. J., & Reichardt, H. M. (2023) · Cancers · doi:10.3390/cancers15092619 · Cited by 11
“The TME of SGCT is pro-inflammatory in nature, which is unusual since tumors normally promote an accumulation of regulatory T cells and macrophages with an M2 phenotype [16].”
BackgroundANO6 is a reliable prognostic biomarker and correlates to macrophage polarization in breast cancer
Tang, L.-H., Dai, M., & Wang, D. (2023) · Medicine · doi:10.1097/md.0000000000036049 · Cited by 14
“[43] Therefore, ANO6 elevation might affect tumor immune microenvironment and accelerate tumor immune escape.”
BackgroundBai, W. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e22885 · Cited by 12
“…considered as anti-tumor, while M2 polarized macrophages, usually considered as Tumor-associated macrophages, contribute to many tumors promoting cancer results through angiogenesis and Lymphatic vessel regulation, immunosuppression, hypoxia induction, tumor cell proliferation, and metastasis [44].”
BackgroundNFATc2 promotes lactate and M2 macrophage polarization through USP17 in lung adenocarcinoma
Wang, L., Ma, Y., Zhang, S., Yang, Y., & Huang, B. (2024) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000001582 · Cited by 13
“Macrophage phenotypes including M1/M2 polarization are mainly depended on the various factors in the tumor microenvironment [4,5].”
BackgroundXu, X., Zhong, D., Wang, X., Luo, F., Zheng, X., Feng, T., Chen, R., Cheng, Y., Wang, Y., & Ma, G. (2024) · Scientific Reports · doi:10.1038/s41598-024-56105-2 · Cited by 13
He, W., Xu, C., Huang, Y., Zhang, Q., Chen, W., Zhao, C., Chen, W., Zheng, D., XinyueLin, Luo, Q., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111519 · Cited by 10
Gao, L., Bai, Y., Zhou, J., Liang, C., Dong, Y., Han, T., Liu, Y., Guo, J., Wu, J., & Hu, D. G. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111179 · Cited by 12
Shan, J., Liu, Z., Chen, S., Du, C., Li, B., Ruan, L.-X., Kong, M., Wang, L., Du, M., Shi, S., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03462-4 · Cited by 11
“Additionally, the ratio of M1/M2 macrophages in non-pCR patients was significantly lower, indicating that the immune microenvironment of non-pCR patients was relatively inhibitory [27, 28].”
BackgroundWang, X., Bai, L., Kong, L., & Guo, Z. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1411731 · Cited by 11
“During advanced stages of tumor, the M2-polarized state can persist for extended durations, promoting angiogenesis, tumor advancement, immune system evasion, and the establishment of immunological tolerance via cytokine release (144, 146 – 148).”
BackgroundBenslimane, Y., Amalfi, K., Lapin, S., Perrino, S., & Brodt, P. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-24-0196 · Cited by 12
“…of macrophage polarization on a spectrum from a pro-inflammatory and tumor-inhibitory (M1) phenotype to an anti-inflammatory pro-tumorigenic (M2) phenotype, a process that is regulated by cytokines, chemokines, and growth factors released by the tumor cells and other immune cells in the TME (11).”
BackgroundChuang, H.-J., Chen, Y., Chung, Y., Huang, E., Huang, C. Y., Lung, J., Chen, C., & Liao, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179737 · Cited by 11
“The previous studies have shown that M2 may be a tumor-associated macrophage (TAM) and promote tumor growth [3,5].”
BackgroundSilveira, A. S. D. A., Alves, A. C. D. A., Gimenes, G. M., Quessada, P. D. S., Lobato, T. B., Dias, B. B., Pereira, A. C. G., Iser‐Bem, P. N., Pereira, J. N. B., Hatanaka, E., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910240 · Cited by 10
Tedeschi, G., Navarro, M. X., Scipioni, L., Sondhi, T. K., Prescher, J. A., & Digman, M. A. (2024) · Chemical & Biomedical Imaging · doi:10.1021/cbmi.4c00049 · Cited by 11
Advances in tumor immunotherapy targeting macrophages
Shi, B., Du, M., & Chen, Z. (2024) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2024.2438721 · Cited by 12
“Therefore, targeted therapy of TAMs has become a promising tumor treatment strategy [6,12].”
Role of exosomal miRNAs and macrophage polarization in gastric cancer: A novel therapeutic strategy
Zhang, Y., Wang, B., Chen, J., & Li, T. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177268 · Cited by 10
Zheng, D., Ning, J., Xia, Y., Ruan, Y., & Fan, C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1008714 · Cited by 10
“The abundance of infiltrating M1 macrophages was positively correlated with clinical outcome in diverse tumor types (47).”
Backgroundde León, U. A.-P., Vázquez-Jiménez, A., Matadamas-Guzman, M. L., & Reséndis-Antonio, O. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1012730 · Cited by 13
Wielgat, P., Rogowski, K., Czarnomysy, R., Wawrusiewicz‐Kurylonek, N., Narejko, K., Bielawski, K., & Car, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065512 · Cited by 10
“Since a reduction in intracellular arginine is known to dampen inflammation and phagocytosis, the high expression of arginase-1 is one of the primary characteristics of M2 polarisation in cancer immunosurveillance [42].”
BackgroundAkshaya, R. L., Saranya, I., & Selvamurugan, N. (2023) · Breast Cancer · doi:10.1007/s12282-023-01491-0 · Cited by 10
“They identified that miR-19a-5p reduced the induction of M2 macrophage polarization, a hallmark of cancer [77], via targeting Fra-1 , a proto-oncogene and regulated the expression of its downstream signaling molecules, including STAT3, pSTAT3, and VEGF both in vitro and in vivo.”
BackgroundPericytes Are Immunoregulatory Cells in Glioma Genesis and Progression
Martínez-Morga, M., Garrigos, D., Rodriguez-Montero, E., Pombero, A., García‐López, R., & Martínez, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105072 · Cited by 11
“In GBM, excluding PCs, TAMs and microglia are the most abundant immunocompetent cells that invade tumors and may initiate M1 anti-tumoral processes [42].”
BackgroundMohanty, C., Singh, C. K., Daccache, J. A., Damsky, W., Kendziorski, C. M., Yan, D., Prasad, A. K., Zhang, D., Keenan, T., Drolet, B. A., et al. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.04.024 · Cited by 11
Tumor-associated macrophages: orchestrators of cholangiocarcinoma progression
Chen, F., Sheng, J., Li, X., Gao, Z., Hu, L., Chen, M., Fei, J., & Song, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1451474 · Cited by 12
CAR-T Therapy Beyond B-Cell Hematological Malignancies
Canichella, M., & de Fabritiis, P. (2025) · Cells · doi:10.3390/cells14010041 · Cited by 11
“HIV is the etiological agent of acquired immunodeficiency syndrome (AIDS), a condition marked by the depletion of CD4+T cells [87].”
Glioblastoma drives protease-independent extracellular matrix invasion of microglia
Chang, C.-W., Bale, A. A., Bhargava, R., & Harley, B. A. C. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101475 · Cited by 19
The feedback loop between miR-222-3p and ZEB1 harnesses metastasis in renal cell carcinoma
Wang, F., Li, L., Sun, X., Cai, X., Wang, J., Luo, H., Wang, Y., Ni, D., & Wang, D. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02385-0 · Cited by 10
“Speci fi cally, M1 macrophages have a protective function, whereas M2 macrophages facilitate tumor progression and metastasis [27, 28].”
Wang, H., Jia, L., Yu, H., Tang, H. D., Chi, H., Zhang, W., & Chen, J. (2025) · Integrative Cancer Therapies · doi:10.1177/15347354251325806 · Cited by 9
“33,34 In addition, due to the rapid proliferation of tumors, hypoxia is an important TME factor of solid tumors, interacting with chemotherapy resistance, radiation resistance, aggressiveness, and angiogenesis.”
Exploring the roles of ncRNAs in prostate cancer via the PI3K/AKT/mTOR signaling pathway
Guo, R., Shi, L., Chen, Y., Lin, C., & Yin, W. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1525741 · Cited by 11
“M2 macrophages promote tumor development by regulating angiogenesis and lymphangiogenesis, immunosuppression, hypoxia induction, and cancer cell proliferation and metastasis (69).”
Wang, Q., Duan, Y., Xu, Y., Li, H., & Yang, Y. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-00928-x · Cited by 9
“M1 macrophages, generally recognized for their anti-tumor properties, may increase melanoma in response to tumor growth 56 .”
Li, Q., Wang, M., Huang, X., Wang, S., Li, C., Li, P., Xiang, W. D., Yao, L., Deng, C., Zhang, M., et al. (2025) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-025-04890-2 · Cited by 13
“They can kill tumor cells either by directly mediating cytotoxicity, such as the release of reactive oxygen species (ROS) and nitrogen monoxide (NO), or by antibody dependent cell-mediated cytotoxicity (ADCC) [9].”
Geng, J., Liang, B., Zhang, Z., Shan, F., Zhao, X., & Yuan, Y. (2025) · Communications Biology · doi:10.1038/s42003-025-08147-z · Cited by 10
“Multiplestudieshaveconsistentlydemonstratedasubstantial increase in the proportion of M2-type TAMs in gliomas, which is strongly correlated with a negative disease prognosis 10,16,18,19 .”
The supporting role of Schwann cells in perineural invasion of pancreatic ductal adenocarcinoma
He, Y., Chen, Z., Yang, L., Qiao, S., Su, Z., Ding, F., Ding, F., Xin, F., Xiang, S., Lü, A., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1540027 · Cited by 11
“TAMs further secrete factors (such as IL-8) to activate PDAC cells and promote PNI (Boutilier and Elsawa, 2021).”
Souza, S. V. D. P., Aguiar, A., de Albuquerque, E. C. S., Eich, C., Cruz, L. J., Lara, P., Jorquera‐Cordero, C., Gomes, R. F., de Paula, R. C. M., Freire, R. S., et al. (2025) · Molecular Carcinogenesis · doi:10.1002/mc.70003 · Cited by 10
Atta, A., Naveed, M., Rahman, M. U., Alioui, Y., Ansari, I., Ali, S., Ghaleb, E., Farooqui, N. A., Abusidu, M., Xin, Y., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146805 · Cited by 10
“In contrast, M2 macrophages, induced by IL-4, produce anti-inflammatory cytokines, particularly IL-10 and TGF-β , promoting tissue repair and immune resolution [18].”
From Spice to Survival: The Emerging Role of Curcumin in Cancer Immunotherapy
Parker, J. M., Zhao, L., Mayberry, T. G., Cowan, B. C., Wakefield, M. R., & Fang, Y. (2025) · Cancers · doi:10.3390/cancers17152491 · Cited by 10
“Cancer cells often promote M2 macrophages by fostering a TME favorable to that phenotype [97].”
Feng, L., Wang, Y., Wang, X., Li, B., Liu, Y., Zhang, W., Ji, J., Shao, L., & Guo, X. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115416 · Cited by 11
Zhang, Z., Sun, X., Gao, Z., Lv, X., Jia, H., Huang, B., Xia, C., & Yang, X. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s528763 · Cited by 9
“21,22 Notably, the balance between M1 and M2 polarization is dynamically reversible in response to microenvironmental cues, 23–25 highlighting the potential for therapeutic interventions that target macrophage phenotypes.”
Visualizing cellular interactions: intravital imaging in tumor microenvironment
Li, S., Liu, L., Shan, J., & Cheng, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1630658 · Cited by 12
“…to tumor regions by various stimuli (chemokines, cytokines, exosomes) and polarized into M1 type (pro-in fl ammatory and anti-tumor) and M2 type (anti-in fl ammatory and pro-tumor) (116) The anti-tumor function of TAMs is primarily mediated through direct phagocytosis of tumor cells upon contact.”
Lactate and lactylation in tumor immunity
Liu, S., Sun, L., Chen, S., & Lan, P. (2025) · Frontiers of Medicine · doi:10.1007/s11684-025-1148-0 · Cited by 12
Metadata
- Authors
- Boutilier, A. J., & Elsawa, S. F.
- Affiliations
- University of New Hampshire (US)
- Corresponding author
- Elsawa, Sherine F.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-06-29
- Volume
- 22
- Issue
- 13
- Pages
- 6995
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8268869
- OpenAlex
- W3173665490
- Cited by
- 1,631
- References
- 148
- Citations by year
- 2026: 281 · 2025: 409 · 2024: 429 · 2023: 359 · 2022: 144 · 2021: 9
- FWCI
- 24.32
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (P20 GM113131)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- macrophage polarization, tumor-associated macrophages, tumor microenvironment, tumor progression, angiogenesis, lymphangiogenesis, immunosuppression, hypoxia, metastasis, macrophage recruitment
- MeSH terms
- Tumor-Associated Macrophages, Animals, Hypoxia, Cell Transformation, Neoplastic, Humans, Inflammation, Macrophage Activation, Neoplasm Metastasis, Neoplasm Staging, Signal Transduction, Biomarkers, Immunophenotyping, Cytokines, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.